Results 41 to 50 of about 1,075 (125)
PRCC-TFE3 dual-fusion FISH assay: A new method for identifying PRCC-TFE3 renal cell carcinoma in paraffin-embedded tissue. [PDF]
PLoS ONE, 2017 PRCC-TFE3 renal cell carcinoma (RCC) is one of the most common types of Xp11.2 translocation renal cell carcinoma (tRCC), of which the diagnosis mainly relies on reverse transcription-polymerase chain reaction (RT-PCR) or chromosomal analysis in fresh ...
Lei Xiong +7 more
doaj +1 more source
The Role of Glycoprotein Non‐Metastatic Melanoma Protein B (GPNMB) in Tumors and Other Diseases
MedComm – Oncology, Volume 4, Issue 3, September 2025.Glycoprotein non‐metastatic melanoma protein B (GPNMB) is is widely involved in biological processes such as tissues, cells, metabolism and immunity, regulates multiple signaling pathways, and plays an important role in the occurrence and development of various diseases, including tumors.
Zhenyu Wu +5 more
wiley +1 more source
Melanotic Xp11 Translocation Renal Cell Carcinoma—A Case Report
Medical Journal of Dr. D.Y. Patil VidyapeethTranslocation-associated renal cell carcinomas are a rare subset of renal epithelial malignancies, most commonly occurring in the pediatric and young adult population.
Shubha Padmanabha Bhat +5 more
doaj +1 more source
Scientific Reports, 2020 NONO-TFE3 RCC is a subtype of Xp11.2 translocation renal cell carcinoma (RCC). So far, only a small amount of NONO-TFE3 RCC have been reported owing to lack of effective diagnosis methods.
Ning Liu +13 more
doaj +1 more source
The Two Faces of Angiopoietin‐Like Protein 2 in Cancer
Cancer Science, Volume 116, Issue 3, Page 592-599, March 2025.In this Review, Horiguchi et al. focus on ANGPTL2 activity in the tumor microenvironment and its function in anti‐cancer immunity. ABSTRACT The tumor microenvironment is composed of tumor cells and various stromal cell types, such as immune cells, fibroblasts, and vascular cells.
Haruki Horiguchi +2 more
wiley +1 more source
Cancer Management and Research, 2021 Yiqi Zhu,1,* Xiaohong Pu,2,* Xiang Dong,3 Changwei Ji,1 Hongqian Guo,1 Dongmei Li,4,5 Xiaozhi Zhao,1 Weidong Gan1 1Department of Urology, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, Nanjing, Jiangsu, People ...
Zhu Y +7 more
doaj
TFE3-rearranged renal cell carcinoma with osseous metaplasia and indolent behaviour
Urology Case Reports, 2022 TFE3-rearranged renal cell carcinoma (RCC) is a rare but well characterised histological subtype of RCC with an aggressive clinical course and propensity for late metastases.
Alessandro Pietro Aldera +2 more
doaj +1 more source
Cytomorphology and clinicopathologic correlation of TFE3‐rearranged renal cell carcinoma
Cancer Cytopathology, Volume 133, Issue 2, February 2025.Abstract Background TFE3‐rearranged renal cell carcinoma (TFE3‐rRCC) harbors gene fusions involving TFE3 with one of many different partner genes. Because of their diverse morphologies, the differential diagnosis is broad and challenging. Publications focusing on the cytomorphology of TFE3‐rRCC are sparse.
Tieying Hou, Xiaoqi Lin
wiley +1 more source
Zhongguo shiyan zhenduanxue, 2020 Xp11.2/TFE3相关性肾细胞癌是一种罕见的肾脏恶性肿瘤,多发生于儿童,仅占成人期肾癌的1.6%-4%,2016年WHO第4版肾脏肿瘤分类标准将Xp11.2/TFE3相关性肾细胞癌归入MiT家族易位性癌,这一名称是因其都含有染色体Xp11.2易位,进而形成TFE3融合基因,从而导致TFE3蛋白的过表达。我院于2018年12月收治了Xp11.2/TFE3相关性肾细胞癌1例,现结合文献复习报告如下。
冯明亮, 高宝山, 周洪澜
doaj
Journal of Clinical Laboratory Analysis, Volume 39, Issue 4, February 2025.This study explores the complementary roles of chromosomal microarray analysis (CMA) and karyotyping in detecting chromosomal mosaicism in prenatal diagnosis. By analyzing 2007 amniocentesis cases, it demonstrates how combining both methods improves detection accuracy, particularly in cases where one method alone may miss subtle abnormalities.
Chenxia Xu +5 more
wiley +1 more source